CATIE Suggests Zyprexa Useful As Initial Schizophrenia Treatment – NEJM

Results of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study suggest Lilly's Zyprexa may be well suited as initial therapy in the treatment of schizophrenia, according to an editorial accompanying the study